Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine
Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been engineered for increased antitumor activity, and are currently under investigation in clinical phase 1 trials. Approaches with other viral vectors have shown that insertion of immunomodulatory transgenes enhance...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 May 2013
|
| In: |
Human gene therapy
Year: 2013, Volume: 24, Issue: 7, Pages: 644-654 |
| ISSN: | 1557-7422 |
| DOI: | 10.1089/hum.2012.205 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1089/hum.2012.205 Verlag, lizenzpflichtig, Volltext: https://www.liebertpub.com/doi/10.1089/hum.2012.205 
|
| Author Notes: | Christian Grossardt, Christine E. Engeland, Sascha Bossow, Niels Halama, Karim Zaoui, Mathias F. Leber, Christoph Springfeld, Dirk Jaeger, Christof von Kalle, and Guy Ungerechts |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1745913858 | ||
| 003 | DE-627 | ||
| 005 | 20230426075021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210128s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/hum.2012.205 |2 doi | |
| 035 | |a (DE-627)1745913858 | ||
| 035 | |a (DE-599)KXP1745913858 | ||
| 035 | |a (OCoLC)1341389350 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Großardt, Christian |e VerfasserIn |0 (DE-588)1044668512 |0 (DE-627)772407045 |0 (DE-576)398026408 |4 aut | |
| 245 | 1 | 0 | |a Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine |c Christian Grossardt, Christine E. Engeland, Sascha Bossow, Niels Halama, Karim Zaoui, Mathias F. Leber, Christoph Springfeld, Dirk Jaeger, Christof von Kalle, and Guy Ungerechts |
| 264 | 1 | |c 3 May 2013 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.02.2021 | ||
| 520 | |a Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been engineered for increased antitumor activity, and are currently under investigation in clinical phase 1 trials. Approaches with other viral vectors have shown that insertion of immunomodulatory transgenes enhances the therapeutic potency. In this study, we engineered MV for expression of the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). For the first time, therapeutic efficacy and adaptive immune response in the context of MV oncolysis could be evaluated in the previously established immunocompetent murine colon adenocarcinoma model MC38cea. MC38cea cells express the human carcinoembryonic antigen (CEA), allowing for infection with retargeted MV. Intratumoral application of MV-GMCSF significantly delayed tumor progression and prolonged median overall survival compared with control virus-treated mice. Importantly, more than one-third of mice treated with MV-GMCSF showed complete tumor remission and rejected successive tumor reengraftment, demonstrating robust long-term protection. An enhanced cell-mediated tumor-specific immune response could be detected by lactate dehydrogenase assay and interferon-γ enzyme-linked immunospot assay. Furthermore, MV-GMCSF treatment correlated with increased abundance of tumor-infiltrating CD3+ lymphocytes analyzed by quantitative microscopy of tumor sections. These findings underline the potential of oncolytic, GM-CSF-expressing MV as an effective therapeutic cancer vaccine actively recruiting adaptive immune responses for enhanced therapeutic impact and tumor elimination. Thus, the treatment benefit of this combined immunovirotherapy approach has direct implications for future clinical trials. | ||
| 700 | 1 | |a Engeland, Christine Elisabeth |d 1985- |e VerfasserIn |0 (DE-588)1025405951 |0 (DE-627)722221193 |0 (DE-576)370314670 |4 aut | |
| 700 | 1 | |a Bossow, Sascha |e VerfasserIn |0 (DE-588)1051960525 |0 (DE-627)787207772 |0 (DE-576)40761852X |4 aut | |
| 700 | 1 | |a Halama, Niels |d 1977- |e VerfasserIn |0 (DE-588)13087325X |0 (DE-627)507228723 |0 (DE-576)251045706 |4 aut | |
| 700 | 1 | |a Plath, Karim |d 1977- |e VerfasserIn |0 (DE-588)140238719 |0 (DE-627)703610813 |0 (DE-576)314596607 |4 aut | |
| 700 | 1 | |a Leber, Mathias Felix |d 1985- |e VerfasserIn |0 (DE-588)1057902306 |0 (DE-627)795388780 |0 (DE-576)413908348 |4 aut | |
| 700 | 1 | |a Springfeld, Christoph |d 1972- |e VerfasserIn |0 (DE-588)123388910 |0 (DE-627)706281039 |0 (DE-576)293689385 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Kalle, Christof von |d 1962- |e VerfasserIn |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
| 700 | 1 | |a Ungerechts, Guy |d 1972- |e VerfasserIn |0 (DE-588)124557902 |0 (DE-627)363420053 |0 (DE-576)294230939 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human gene therapy |d New York, NY : Liebert, 1990 |g 24(2013), 7, Seite 644-654 |h Online-Ressource |w (DE-627)306585332 |w (DE-600)1498064-2 |w (DE-576)094476950 |x 1557-7422 |7 nnas |a Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine |
| 773 | 1 | 8 | |g volume:24 |g year:2013 |g number:7 |g pages:644-654 |g extent:11 |a Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine |
| 856 | 4 | 0 | |u https://doi.org/10.1089/hum.2012.205 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.liebertpub.com/doi/10.1089/hum.2012.205 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210128 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 124557902 |a Ungerechts, Guy |m 124557902:Ungerechts, Guy |d 910000 |d 910100 |d 50000 |e 910000PU124557902 |e 910100PU124557902 |e 50000PU124557902 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 |y j | ||
| 998 | |g 1036481115 |a Kalle, Christof von |m 1036481115:Kalle, Christof von |d 910000 |e 910000PK1036481115 |k 0/910000/ |p 9 | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 8 | ||
| 998 | |g 123388910 |a Springfeld, Christoph |m 123388910:Springfeld, Christoph |d 910000 |d 910100 |e 910000PS123388910 |e 910100PS123388910 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1057902306 |a Leber, Mathias Felix |m 1057902306:Leber, Mathias Felix |d 140000 |e 140000PL1057902306 |k 0/140000/ |p 6 | ||
| 998 | |g 140238719 |a Plath, Karim |m 140238719:Plath, Karim |d 910000 |d 911000 |e 910000PP140238719 |e 911000PP140238719 |k 0/910000/ |k 1/910000/911000/ |p 5 | ||
| 998 | |g 13087325X |a Halama, Niels |m 13087325X:Halama, Niels |d 910000 |d 910100 |e 910000PH13087325X |e 910100PH13087325X |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1051960525 |a Bossow, Sascha |m 1051960525:Bossow, Sascha |d 50000 |e 50000PB1051960525 |k 0/50000/ |p 3 | ||
| 998 | |g 1025405951 |a Engeland, Christine Elisabeth |m 1025405951:Engeland, Christine Elisabeth |d 50000 |e 50000PE1025405951 |k 0/50000/ |p 2 | ||
| 998 | |g 1044668512 |a Großardt, Christian |m 1044668512:Großardt, Christian |d 140000 |e 140000PG1044668512 |k 0/140000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1745913858 |e 384369365X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"11 S."}],"id":{"eki":["1745913858"],"doi":["10.1089/hum.2012.205"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 17.02.2021"],"relHost":[{"part":{"year":"2013","pages":"644-654","text":"24(2013), 7, Seite 644-654","volume":"24","extent":"11","issue":"7"},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1990 -"],"id":{"eki":["306585332"],"issn":["1557-7422"],"zdb":["1498064-2"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title_sort":"Human gene therapy","title":"Human gene therapy"}],"recId":"306585332","disp":"Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccineHuman gene therapy","origin":[{"dateIssuedKey":"1990","publisherPlace":"New York, NY","publisher":"Liebert","dateIssuedDisp":"1990-"}]}],"person":[{"given":"Christian","display":"Großardt, Christian","family":"Großardt","role":"aut"},{"role":"aut","given":"Christine Elisabeth","display":"Engeland, Christine Elisabeth","family":"Engeland"},{"role":"aut","family":"Bossow","given":"Sascha","display":"Bossow, Sascha"},{"role":"aut","family":"Halama","given":"Niels","display":"Halama, Niels"},{"role":"aut","display":"Plath, Karim","given":"Karim","family":"Plath"},{"role":"aut","display":"Leber, Mathias Felix","given":"Mathias Felix","family":"Leber"},{"role":"aut","family":"Springfeld","display":"Springfeld, Christoph","given":"Christoph"},{"family":"Jäger","given":"Dirk","display":"Jäger, Dirk","role":"aut"},{"family":"Kalle","given":"Christof von","display":"Kalle, Christof von","role":"aut"},{"role":"aut","family":"Ungerechts","given":"Guy","display":"Ungerechts, Guy"}],"name":{"displayForm":["Christian Grossardt, Christine E. Engeland, Sascha Bossow, Niels Halama, Karim Zaoui, Mathias F. Leber, Christoph Springfeld, Dirk Jaeger, Christof von Kalle, and Guy Ungerechts"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"3 May 2013"}],"recId":"1745913858","title":[{"title_sort":"Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine","title":"Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine"}],"language":["eng"]} | ||
| SRT | |a GROSSARDTCGRANULOCYT3201 | ||